Published in Am J Cardiol on June 01, 1979
Coronary artery spasm--pathophysiology, clinical presentations, diagnostic approaches and rational treatment. West J Med (1982) 1.07
Coronary artery spasm: a review. J R Soc Med (1980) 0.80
Coronary and peripheral arterial responses to ergometrine in patients susceptible to coronary and oesophageal spasm. Br Heart J (1981) 0.80
The haemodynamic response to myocardial ischaemia in ambulant patients with variant angina. Br Heart J (1986) 0.79
Severe myocardial ischaemia induced by intravenous adrenaline. Br Med J (Clin Res Ed) (1983) 0.78
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol. Br J Clin Pharmacol (1982) 0.78
Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker. Br Heart J (1983) 0.78
Platelet reactivity and its dependence on alpha-adrenergic receptor function in patients with ischaemic heart disease. Br Heart J (1983) 0.77
Spontaneous remission in variant angina. Br Heart J (1981) 0.75
Change in heart rate variability preceding ST elevation in a patient with vasospastic angina pectoris. Heart Vessels (1998) 0.75
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
An artificial standard for use in the estimation of haemoglobin. Biochem J (1945) 6.45
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 3.32
Ultrasonic cardiac echography for determining stroke volume and valvular regurgitation. Circulation (1970) 3.22
Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med (1974) 2.89
Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med (1967) 2.41
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation (1974) 2.16
Ultrasound for the diagnosis of atrial tumor. Ann Intern Med (1969) 2.16
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med (1999) 2.02
Propranolol in patients with angina pectoris. Ann Intern Med (1967) 1.90
Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation (1971) 1.88
The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods (2000) 1.70
Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience (2001) 1.69
Early anthracycline cardiotoxicity. Am J Med (1978) 1.63
Patients admitted to the coronary care unit for chest pain: high risk subgroup for subsequent cardiovascular death. Am J Cardiol (1977) 1.62
A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med (1993) 1.55
Cytochrome c as a carrier with the glucose dehydrogenase system. Biochem J (1939) 1.54
Saphenous vein coronary artery bypass in patients with "preinfarction angina". Circulation (1973) 1.52
Should lidocaine be administered routinely to all patients after acute myocardial infarction? Circulation (1978) 1.52
Valve replacement in active bacterial endocarditis. N Engl J Med (1967) 1.50
Left main intervention revisited: early and late outcome of PTCA and stenting. Cathet Cardiovasc Diagn (1997) 1.50
Echocardiographic features of primary pulmonary hypertension. Am J Cardiol (1974) 1.49
Role of concentration-dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm (1979) 1.49
Evaluation of the portable chest roentgenogram for quantitating extravascular lung water in critically ill adults. Chest (1985) 1.49
Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol (1972) 1.45
Effect of transducer placement on echocardiographic measurement of left ventricular dimensions. Am J Cardiol (1975) 1.44
Results of direct coronary-artery surgery for the treatment of angina pectoris. N Engl J Med (1973) 1.44
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev (2001) 1.43
Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging (1994) 1.42
Coronary arterial narrowing in Takayasu's aortitis. Am J Cardiol (1977) 1.40
Multiple coronary stenting in unstable angina: early and late clinical outcomes. Cathet Cardiovasc Diagn (1998) 1.38
Echocardiographic findings in discrete subvalvular aortic stenosis. Circulation (1974) 1.38
Changes in diastolic stiffness and tone of the left ventricle during angina pectoris. Circulation (1974) 1.37
Aortic valve replacement with and without coronary artery bypass surgery. Circulation (1974) 1.37
Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man. Res Commun Chem Pathol Pharmacol (1976) 1.36
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. Br Heart J (1975) 1.35
Long-term tocainide therapy for ventricular arrhythmias. Circulation (1978) 1.35
Vitamin D in ergot of rye. Biochem J (1929) 1.34
Pulmonary hypertension in patients using oral contraceptives. A report of six cases. Chest (1976) 1.31
Verapamil disposition kinetics in chronic atrial fibrillation. Clin Pharmacol Ther (1981) 1.31
Cardiac transplantation in man. Review of first three years' experience. Am J Med (1973) 1.30
Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept (2002) 1.28
Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J (1981) 1.27
A new catheter system for coronary angioplasty. Am J Cardiol (1982) 1.26
Comparison of dobutamine and dopamine in treatment of severe heart failure. Br Heart J (1977) 1.25
Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol. Circulation (1968) 1.25
Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation (1975) 1.22
Arrhythmias after cardiac transplantation. Am J Cardiol (1974) 1.21
Propranolol in the treatment and prevention of cardiac arrhythmias. Ann Intern Med (1967) 1.20
High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite. J Chromatogr (1977) 1.20
Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med (1976) 1.20
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J (1983) 1.19
Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol (1985) 1.19
Clinical pharmacology of propafenone. Circulation (1983) 1.19
Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol (1977) 1.18
Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol (1971) 1.18
Left ventricular abnormalities in arrhythmogenic right ventricular dysplasia. Am J Cardiol (1986) 1.17
Influence of potassium depletion on myocardial concentration of tritiated digoxin. Circ Res (1967) 1.17
An improved method for echographic detection of left atrial enlargement. Circulation (1974) 1.15
Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide. Circulation (1976) 1.15
Acute haemodynamic effects of practolol in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J (1973) 1.13
The use of central venous oxygen sturation measurements in a coronary care unit. Ann Intern Med (1968) 1.12
Effect of digoxin on atioventricular conduction. Studies in patients with and without cardiac autonomic innervation. Circulation (1975) 1.11
Measurement of central venous oxygen saturation in patients with myocarial infarction. Circulation (1968) 1.10
Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis. Circulation (1969) 1.10
Echocardiographic abnormalities in the mitral valve prolapse syndrome. Circulation (1974) 1.09
The effect of propranolol on exercise-induced ischemic S-T segment depression. Am J Cardiol (1969) 1.09
The relation between myocardial 3 H-digoxin concentration and its hemodynamic effects. Am J Cardiol (1972) 1.08
The inotropic effects of digoxin in hyperkalemia. Relation to (Na+,K+)-ATPase inhibition in the intact animal. Circulation (1973) 1.07
Prolongation of verapamil elimination kinetics during chronic oral administration. Am Heart J (1982) 1.07
Coronary artery spasm--pathophysiology, clinical presentations, diagnostic approaches and rational treatment. West J Med (1982) 1.07
Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol (1979) 1.07
Histamine and the human heart: the other receptor system. Am J Cardiol (1982) 1.07
Calcium overload, "injury" current, and early ischaemic cardiac arrhythmias--a direct connection. Lancet (1983) 1.07
Arrhythmias in patients with mitral valve prolapse. Circulation (1975) 1.06
Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists. Chest (1980) 1.06
Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol (1982) 1.05
Prinzmetal's variant of angina pectoris with only slight coronary atherosclerosis. Calif Med (1968) 1.05
Surgical management of life-threatening ventricular arrhythmias in patients with coronary artery disease. Circulation (1977) 1.05
Valvular-ventricular interaction: importance of the mitral apparatus in canine left ventricular systolic performance. Circulation (1986) 1.05
Autonomic nervous system and arrhythmias: studies in the transplanted denervated human heart. Cardiology (1976) 1.04
Mannose as a possible precursor of ascorbic acid in the tissues of the rat. Biochem J (1937) 1.04
Hemodynamic effects of morphine and pentazocine differ in cardiac patients. N Engl J Med (1972) 1.03
Light-pen computer processing of video image for the determination of left ventricular volume. Circulation (1973) 1.03
The expression of GABA(B1) and GABA(B2) receptor subunits in the cNS differs from that in peripheral tissues. Neuroscience (2000) 1.03
A new look at an old problem: mushroom poisoning. Clinical presentations and new therapeutic approaches. Am J Med (1975) 1.03
Electrophysiologic studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propranolol. Am J Cardiol (1975) 1.02
The clinical spectrum of papillary-muscle disease. N Engl J Med (1969) 1.02
Long-term serial angiographic studies after coronary artery bypass surgery. Circulation (1979) 1.02
Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation (1974) 1.02
Acute rejection in the long-term cardiac transplant survivor. Clinical diagnosis, treatment and significance. Circulation (1974) 1.01
Diagnosis of left atrial myxoma by echocardiography. N Engl J Med (1970) 1.01
Histamine receptors in the human heart. Life Sci (1980) 1.00
Electrophysiological studies in the denervated transplanted human heart. Response to trial pacing and atropine. Circ Res (1973) 1.00
Balloon embolization of latrogenic aortocoronary arteriovenous fistula. Cathet Cardiovasc Diagn (1990) 1.00